Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | CES1 | P23141 | 7/20 | 0.43 |
| ▸ | CES2 | O00748 | 6/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 4/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30213710 | 0.94 | HIF1A (0.47) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL1296671 | 0.86 | OR51E2 (0.50) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL30439607 | 0.84 | FAAH (0.48) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL5158249 | 0.84 | HIF1A (0.43) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL28645746 | 0.84 | CES2 (0.44) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL28774839 | 0.82 | — | — | |
| Benzene SCHEMBL8775366 | 0.82 | OR51E2 (0.46) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL11861055 | 0.81 | HIF1A (0.53) | HIF1ATSHRMAPTFAAHTRPV1 | |
| SCHEMBL17354916 | 0.80 | HIF1A (0.39) | HIF1ACES1CES2TSHRMAPT | |
| SCHEMBL11676576 | 0.80 | MAPT (0.56) | TSHRMAPTFAAHLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7967992-B2 | Method and device incorporating granular particles and disc-shaped plastic pellets for filtering water | RICURA TECHNOLOGIES, LLC (US) | 2011-06-28 | — | — | US | claimed |
| US-20110104097-A1 | TOPICAL COMPOSITIONS FOR THE PRESERVATION OF A HUMAN OR ANIMAL BODY | ARKEMA FRANCE (FR) | 2011-05-05 | — | — | US | claimed |
| US-7309429-B2 | Granular filtration device for water | RICURA TECHNOLOGIES, LLC (US) | 2007-12-18 | — | — | US | claimed |
| US-20060163137-A1 | Granular filtration device for water | RICURA TECHNOLOGIES, LLC | 2006-07-27 | — | — | US | claimed |
| US-20060163136-A1 | Novel liquid flow facilitator | RICURA TECHNOLOGIES, LLC | 2006-07-27 | — | — | US | claimed |
| CN-110950832-B | Cyclic compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-20120157548-A1 | USE OF CYCLOALIPHATIC DIOLS AS BIOCIDES | BASF SE (DE) | 2012-06-21 | — | — | US | disclosed |
| US-20120152149-A1 | USE OF 1,3-DIOLS AS BIOCIDES | BASF SE (DE) | 2012-06-21 | — | — | US | disclosed |
| US-20110287245-A1 | WATER-RESISTANT SILICA-EMBEDDED TEXTILES | SHAMEI ALI (IR) | 2011-11-24 | — | — | US | disclosed |
| US-20110281487-A1 | GAS BARRIER MOLDED ARTICLE AND METHOD FOR PRODUCING THE SAME | KAO CORPORATION (JP) | 2011-11-17 | — | — | US | disclosed |
| US-8044105-B2 | Water-based ceramic foams showing improved gel strength | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-10-25 | — | — | US | disclosed |
| EP-2371892-A1 | GAS-BARRIER MATERIAL, GAS-BARRIER MOLDED ARTICLE, AND METHOD FOR PRODUCING THE GAS-BARRIER MOLDED ARTICLE | Kao Corporation (JP) | 2011-10-05 | — | — | EP | disclosed |
| US-20110104097-A1 | TOPICAL COMPOSITIONS FOR THE PRESERVATION OF A HUMAN OR ANIMAL BODY | ARKEMA FRANCE (FR) | 2011-05-05 | — | — | US | disclosed |
| US-7705189-B2 | Calixarene compound, process for producing the same, intermediate therefor, and composition thereof | JSR CORPORATION (JP) | 2010-04-27 | — | — | US | disclosed |
| US-7258702-B2 | Yellow cationic dyes for dyeing of organic material | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-08-21 | — | — | US | disclosed |
| US-20070123736-A1 | Calixarene compound, process for producing the same, intermediate therefor, and composition thereof | JSR CORPORATION (JP) | 2007-05-31 | — | — | US | disclosed |
| EP-1712537-A1 | CALIXARENE COMPOUND, PROCESS FOR PRODUCING THE SAME, INTERMEDIATE THEREFOR, AND COMPOSITION THEREOF | JSR Corporation (JP) | 2006-10-18 | — | — | EP | disclosed |
| US-20060163136-A1 | Novel liquid flow facilitator | RICURA TECHNOLOGIES, LLC | 2006-07-27 | — | — | US | disclosed |
| US-20050120493-A1 | Process for exchanging the anions of cationic compounds | CIBA SPECIALTY CHEMICALS CORP. | 2005-06-09 | — | — | US | disclosed |
| US-20050000034-A1 | Yellow cationic dyes for dyeing of organic material | CIBA SPECIALTY CHEMICALS CORPORATION | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050120493-A1 | Process for exchanging the anions of cationic compounds | SLC10A6, SLC43A1, SLCO4C1 | HIF1A 4029/4885CES1 1392/4885CES2 2144/4885 |
| US-20050000034-A1 | Yellow cationic dyes for dyeing of organic material | KRT18, PYCR1, CYC1 | HIF1A 2366/4885CES1 2941/4885CES2 1184/4885 |
| US-20120157548-A1 | USE OF CYCLOALIPHATIC DIOLS AS BIOCIDES | DDT, DBH, GABBR1 | HIF1A 4220/4885CES1 1973/4885CES2 193/4885 |
| US-20110104097-A1 | TOPICAL COMPOSITIONS FOR THE PRESERVATION OF A HUMAN OR ANIMAL BODY | FUCA1, PIGS, UNG | HIF1A 3413/4885CES1 1111/4885CES2 211/4885 |
| US-20070123736-A1 | Calixarene compound, process for producing the same, intermediate therefor, and composition thereof | CANX, CALU, ACSL1 | HIF1A 1478/4885CES1 210/4885CES2 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.